Tevogen Bio Holdings Inc. (TVGN)
Healthcare
Biotechnology
7.00 $
-0.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Tevogen Bio Holdings Inc. (TVGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -2.7 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.2 | -1.8 | -2.0 | -2.2 | -3.0 | -3.8 | -3.0 | -3.3 | -3.2 | -3.6 | -2.2 | -2.7 | -12 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.2 | 0.1 | 0.1 | 0.0 | 0.3 | -0.2 | 0.1 | 0.2 | |
| 0.0 | 0.0 | – | 26 | 4.1 | 3.3 | 7.0 | 7.3 | 3.2 | 3.2 | 2.4 | 2.8 | 12 | |
| -0.1 | 0.4 | -0.1 | 0.5 | 1.4 | -1.1 | -0.7 | -0.3 | -1.2 | -1.1 | 0.0 | -0.2 | -2.5 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | |
| – | – | 9.6 | – | – | – | – | – | – | – | -0.1 | – | – | |
| – | -333 | -9.7 | – | – | 334 | – | -334 | – | – | – | – | – | |
| – | – | – | – | – | 1.0 | 0.0 | 2.0 | 1.4 | 0.0 | 0.0 | 2.0 | 3.4 | |
| 0.9 | 1.0 | 0.4 | 2.4 | 2.8 | 5.0 | 2.0 | 4.0 | 1.9 | 4.0 | 1.8 | 2.9 | 11 | |
| 0.5 | -0.2 | 0.7 | 0.3 | -0.2 | 1.2 | -1.0 | 0.7 | -1.3 | 0.4 | -0.5 | 0.1 | -1.3 | |
| -2.2 | -1.8 | -2.0 | -2.2 | -3.0 | -3.8 | -3.0 | -3.3 | -3.2 | -3.6 | -2.2 | -2.7 | -12 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.